Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?

被引:0
作者
Nosratola D Vaziri
机构
[1] ND Vaziri is Professor of Medicine,Physiology and Biological Science and Director of the Division of Nephrology and Hypertension at the University of California
[2] Irvine,undefined
[3] CA,undefined
[4] USA.,undefined
来源
Nature Clinical Practice Nephrology | 2008年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
In this Review, Nosratola Vaziri endeavors to reconcile two apparently conflicting sets of evidence from patients with chronic kidney disease: the observational association between greater severity of anemia and increased risk of poor outcomes, and the increased risk of adverse outcomes in patients assigned to normal, rather than subnormal, hemoglobin targets in randomized clinical trials. The author focuses on data from basic and translational studies, which are often overlooked in the design and interpretation of clinical studies and in the formulation of clinical guidelines.
引用
收藏
页码:436 / 445
页数:9
相关论文
共 128 条
[51]  
Sindhu RK(2004)Mechanisms of plaque vulnerability and rupture Cardiovasc Pathol 13 125-138
[52]  
Vaziri ND(2006)The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach Nat Clin Pract Nephrol 2 582-593
[53]  
Rodriguez-Iturbe B(2006)Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension Kidney Int 70 371-376
[54]  
Vaziri ND(2007)Naïve and central memory T cell lymphopenia in end-stage renal disease Curr Opin Lipidol 18 427-434
[55]  
Khan M(2006)The paradox of dysfunctional high-density lipoprotein Nat Clin Pract Endocrinol Metab 2 504-511
[56]  
Schiffrin EL(2007)Mechanisms of Disease: proatherogenic HDL—an evolving field Kidney Int 72 1149-1156
[57]  
Hansson GK(2007)HDL-inflammatory index correlates with poor outcome in hemodialysis patients J Am Soc Nephrol 18 394-400
[58]  
Libby P(2006)Molecular control of iron transport Clin Cancer Res 12 332-339
[59]  
Shah PK(1999)Erythropoietin biology in cancer Am J Kidney Dis 33 821-828
[60]  
Aikawa M(2001)Mechanism of erythropoietin-induced hypertension Curr Opin Nephrol Hypertens 10 633-637